Cargando…

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis

OBJECTIVES: We evaluated the 6-week mortality of SARS-CoV-2 hospitalized patients treated using a standardized protocol in 2020 in Marseille, France. METHODS: A retrospective monocentric cohort study was conducted in the standard hospital wards at the Institut Hospitalo-Universitaire Méditerranée In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagier, Jean-Christophe, Million, Matthieu, Cortaredona, Sébastien, Delorme, Léa, Colson, Philippe, Fournier, Pierre-Edouard, Brouqui, Philippe, Raoult, Didier, Parola, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167052/ https://www.ncbi.nlm.nih.gov/pubmed/35669696 http://dx.doi.org/10.2147/TCRM.S364022

Ejemplares similares

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
por: Million, Matthieu, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Life-years lost by COVID-19 patients in public hospitals of Marseille (APHM-South-Eastern France): a limited death toll: a retrospective analysis
por: Arlotto, Sylvie, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Rabies Postexposure Prophylaxis for Travelers Injured by Nonhuman Primates, Marseille, France, 2001–2014
por: Blaise, Agathe, et al.
Publicado: (2015)

Rabies Postexposure Prophylaxis, Marseille, France, 1994–2005
por: Gautret, Philippe, et al.
Publicado: (2008)

Different pattern of the second outbreak of COVID-19 in Marseille, France
por: Gautret, Philippe, et al.
Publicado: (2021)

Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677 in various lineages in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2021)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Introduction of the SARS-CoV-2 Beta variant from Comoros into the Marseille geographical area
por: Hoang, Van Thuan, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Autochthonous human and animal leptospirosis, Marseille, France
por: Sanchez Fernandez, Pablo, et al.
Publicado: (2020)

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
por: Amrane, Sophie, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021
por: Fournier, Pierre-Edouard, et al.
Publicado: (2022)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France
por: Ly, Tran Duc Anh, et al.
Publicado: (2017)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
por: Fournier, Pierre-Edouard, et al.
Publicado: (2021)

Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999–2003
por: Parola, Philippe, et al.
Publicado: (2006)

Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
por: Cassir, Nadim, et al.
Publicado: (2020)

Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of France
por: Arlotto, Sylvie, et al.
Publicado: (2022)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
por: Cassir, Nadim, et al.
Publicado: (2022)

Respiratory viruses within homeless shelters in Marseille, France
por: Thiberville, Simon-djamel, et al.
Publicado: (2014)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics
por: La Scola, Bernard, et al.
Publicado: (2021)

No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Lebeaux, David, et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France
por: Lagier, J.-C., et al.
Publicado: (2018)

Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France
por: Abat, Cédric, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_huhtojr7ok236q6rput6j0e50p